Total Payments
$2,444
2024 Payments
$354.19
Companies
11
Transactions
22
Medicare Patients
272
Medicare Billing
$37,703

Payment Breakdown by Category

Food & Beverage$2,379 (97.3%)
Education$64.99 (2.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,379 21 97.3%
Education $64.99 1 2.7%

Top Paying Companies

Company Total Records Latest Year
Mallinckrodt Hospital Products Inc. $558.84 5 $0 (2022)
Amgen Inc. $366.04 3 $0 (2022)
SANOFI-AVENTIS U.S. LLC $299.32 3 $0 (2023)
Kite Pharma, Inc. $249.98 2 $0 (2024)
Horizon Therapeutics plc $249.86 2 $0 (2021)
E.R. Squibb & Sons, L.L.C. $229.20 2 $0 (2024)
AstraZeneca Pharmaceuticals LP $124.89 1 $0 (2021)
Aurinia Pharma U.S., Inc. $110.73 1 $0 (2022)
ABBVIE INC. $107.60 1 $0 (2022)
Alexion Pharmaceuticals, Inc. $98.25 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $354.19 3 E.R. Squibb & Sons, L.L.C. ($229.20)
2023 $348.25 4 SANOFI-AVENTIS U.S. LLC ($299.32)
2022 $782.97 7 Mallinckrodt Hospital Products Inc. ($224.96)
2021 $958.23 8 Mallinckrodt Hospital Products Inc. ($333.88)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/15/2024 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $124.99 General
Category: CELLT
06/13/2024 E.R. Squibb & Sons, L.L.C. ABECMA (Biological) Food and Beverage Cash or cash equivalent $104.21 General
Category: Oncology
05/01/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $124.99 General
12/05/2023 SANOFI-AVENTIS U.S. LLC REZUROCK (Drug) Food and Beverage In-kind items and services $131.33 General
Category: Oncology
10/25/2023 SANOFI-AVENTIS U.S. LLC KEVZARA (Biological) Education In-kind items and services $64.99 General
Category: Rheumatology
06/13/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $48.93 General
04/20/2023 SANOFI-AVENTIS U.S. LLC REZUROCK (Drug) Food and Beverage In-kind items and services $103.00 General
Category: Oncology
07/22/2022 Alexion Pharmaceuticals, Inc. STRENSIQ (Biological) Food and Beverage In-kind items and services $98.25 General
Category: Rare Disease
05/18/2022 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $124.99 General
Category: IMMUNOLOGY
05/17/2022 Kite Pharma, Inc. Yescarta (Drug) Food and Beverage In-kind items and services $124.99 General
Category: CELLT
05/10/2022 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $116.44 General
Category: Inflammation
03/31/2022 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $99.97 General
Category: IMMUNOLOGY
03/09/2022 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $110.73 General
Category: LUPUS NEPHRITIS
02/23/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $107.60 General
Category: IMMUNOLOGY
09/15/2021 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $124.88 General
Category: PENNSAID
08/26/2021 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $124.89 General
Category: Oncology
08/11/2021 Horizon Therapeutics plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $124.98 General
Category: RAYOS
07/21/2021 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $124.89 General
Category: Inflammation
05/14/2021 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $101.79 General
Category: IMMUNOLOGY
05/06/2021 Amgen Inc. Food and Beverage In-kind items and services $124.71 General
04/23/2021 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $120.71 General
Category: IMMUNOLOGY
01/21/2021 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $111.38 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 153 417 $103,259 $21,612
2022 3 104 218 $64,088 $14,088
2021 1 15 42 $11,662 $2,003
Total Patients
272
Total Services
677
Medicare Billing
$37,703
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 65 97 $39,507 $9,023 22.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 30 108 $41,688 $8,361 20.1%
G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th Facility 2023 25 152 $18,848 $3,013 16.0%
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or Facility 2023 33 60 $3,216 $1,215 37.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 48 71 $27,628 $6,839 24.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 24 91 $33,670 $6,073 18.0%
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or Facility 2022 32 56 $2,790 $1,175 42.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 15 42 $11,662 $2,003 17.2%

About Kimberly Crasti

Kimberly Crasti is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2018. The National Provider Identifier (NPI) number assigned to this provider is 1962979005.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Crasti has received a total of $2,444 in payments from pharmaceutical and medical device companies, with $354.19 received in 2024. These payments were reported across 22 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,379).

As a Medicare-enrolled provider, Crasti has provided services to 272 Medicare beneficiaries, totaling 677 services with total Medicare billing of $37,703. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.

Practice Information

Products in Payments

  • ACTHAR (Biological) $558.84
  • Yescarta (Drug) $249.98
  • Enbrel (Biological) $241.33
  • REZUROCK (Drug) $234.33
  • RAYOS (Drug) $124.98
  • CALQUENCE (Drug) $124.89
  • PENNSAID (Drug) $124.88
  • LUPKYNIS (Drug) $110.73
  • RINVOQ (Biological) $107.60
  • ABECMA (Biological) $104.21
  • STRENSIQ (Biological) $98.25
  • KEVZARA (Biological) $64.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Buffalo